No muscle atrophy without GSK-3β. Focus on "Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy"

被引：2
|
作者：
Dupont-Versteegden, Esther E. [1 ]
Waters, Christine [1 ]
机构：
[1] Univ Kentucky, Div Phys Therapy, Dept Rehabil Sci, Coll Hlth Sci, Lexington, KY 40536 USA
来源：
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY | 2011年 / 301卷 / 05期
关键词：
GROWTH-FACTOR-I; BETA-CATENIN; UBIQUITIN LIGASES; PATHWAY; INSULIN; RATS; HYPERTROPHY; INHIBITORS; EXPRESSION;
D O I：
10.1152/ajpcell.00310.2011
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：C980 / C981
页数：2
相关论文
共 50 条
  • [1] Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy
    Verhees, Koen J. P.
    Schols, Annemie M. W. J.
    Kelders, Marco C. J. M.
    den Kamp, Celine M. H. Op
    van der Velden, Jos L. J.
    Langen, Ramon C. J.
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2011, 301 (05): : C995 - C1007
  • [2] Glycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and Imaging
    Pandey, Mukesh K.
    DeGrado, Timothy R.
    THERANOSTICS, 2016, 6 (04): : 571 - 593
  • [3] Glycogen synthase kinase-3 (GSK-3) inhibitors reach the clinic
    Medina, Miguel
    Castro, Ana
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2008, 11 (04) : 533 - 543
  • [4] Glycogen synthase kinase-3β (GSK-3β) and its dysregulation in glioblastoma multiforme
    Atkins, R. J.
    Stylli, S. S.
    Luwor, R. B.
    Kaye, A. H.
    Hovens, C. M.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2013, 20 (09) : 1185 - 1192
  • [5] Regulation of Skeletal Muscle Plasticity by Glycogen Synthase Kinase-3β: A Potential Target for the Treatment of Muscle Wasting
    Verhees, Koen J. P.
    Pansters, Nicholas A. M.
    Schols, Annemie M. W. J.
    Langen, Ramon C. J.
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (18) : 3276 - 3298
  • [6] Glycogen Synthase Kinase-3 (GSK-3) Inhibitors for the Treatment of Alzheimer's Disease
    Medina, Miguel
    Avila, Jesus
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (25) : 2790 - 2798
  • [7] Targeting glycogen kinase-3 (GSK-3) in the treatment if Type 2 diabetes
    MacAulay, Katrina
    Woodgett, James R.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2008, 12 (10) : 1265 - 1274
  • [8] Dysregulation of Glycogen Synthase Kinase-3 in Skeletal Muscle and the Etiology of Insulin Resistance and Type 2 Diabetes
    Henriksen, Erik J.
    CURRENT DIABETES REVIEWS, 2010, 6 (05) : 285 - 293
  • [9] Glycogen synthase kinase-3 (GSK-3) activity regulates mRNA methylation in mouse embryonic stem cells
    Faulds, Kelsie J.
    Egelston, Jennifer N.
    Sedivy, Laura J.
    Mitchell, Matthew K.
    Garimella, Sanjana
    Kozlowski, Hanna
    D'Alessandro, Angelo
    Hansen, Kirk C.
    Balsbaugh, Jeremy L.
    Phiel, Christopher J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (27) : 10731 - 10743
  • [10] Design, synthesis and evaluation of 7-azaindazolyl-indolylmaleimides as glycogen synthase kinase-3β (GSK-3β) inhibitors
    Ye, Qing
    Shen, Yanhong
    Zhou, Yubo
    Lv, Dan
    Gao, Jianrong
    Li, Jia
    Hu, Yongzhou
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 68 : 361 - 371
12345